MAPT and Alzheimer disease: Models such as the rTg4510 and PS19 tau transgenic mice, which express mutant tau protein, effectively simulate the formation of NFTs and associated neurodegeneration, aligning with the late-stage characteristics of AD (Jankowsky and Zheng, 2017).